DGAP-News: Medisana AG: Significant earnings improvement, Mobile health encounters enormous interest
(firmenpresse) - DGAP-News: Medisana AG / Key word(s): Final Results
Medisana AG: Significant earnings improvement, Mobile health
encounters enormous interest
02.05.2012 / 18:24
---------------------------------------------------------------------
Neuss, May 2, 2012 - MEDISANA reports consolidated revenue up from EUR 46.3
million to EUR 47.3 million in the 2011 financial year, despite its
interest in Gimelli Laboratories Co. Ltd. (Gimelli) being consolidated only
until the end of September. The company thereby achieved a new record
revenue level in its corporate history.
Operating earnings (EBIT) improved significantly, as planned. MEDISANA
generated earnings before interest and tax (EBIT) of EUR -0.4 million
(previous year: EUR -3.6 million). Although the cost of sales increased due
to intense competition in 2011, and the functional areas' operating
expenses were up slightly, the company offset this through positive effects
arising from the sale of its interest in Gimelli. Other operating expenses
fell by 46.1 percent to EUR 1.1 million, and at EUR 4.3 million, other
operating income was significantly higher than the previous year's EUR 1.6
million. Consolidated earnings after tax improved significantly as a
consequence, amounting to EUR -0.4 million (previous year: EUR -5.9
million), and earnings per share stood at EUR -0.05, compared with EUR
-0.77 in the previous year.
The spin-off of Gimelli is also reflected in the balance sheet. Total
assets fell by EUR 9.6 million to EUR 32.5 million, which, together with
the almost breakeven earnings position, fed through to an increase in the
equity ratio to 33.7 percent (previous year: 25.2 percent). With its equity
capital base, as well as free credit lines and cash and cash equivalents
amounting to EUR 2.8 million as of the balance sheet date, MEDISANA
continues to regard itself as sufficiently financed.
Innovating home health care
MEDISANA's focus on innovation has already proved worthwhile. Product
developments in the Home of Wellness, blood glucose and Mobile Health areas
have been taken up very positively on the markets. In particular, mobile
health products from the VitaDock series are already encountering major
attention from the media and industry worldwide. Users can record, save,
evaluate and transfer their results via Smartphone and tablet PC in order
to monitor their own health. The customer base is enormous and growing
considering Apple, selling 37 million iPhones in the fourth quarter of 2011
alone. MEDISANA AG will continue to consistently implement its corporate
strategy to be one of the most innovative brands, especially in mobile
health care, according to CEO Ralf Lindner. Therefore MEDISANA will
continue to invest in the development of the VitaDock product range.
MEDISANA has achieved considerable relief on the cost side through the sale
of Gimelli, while at the same time, their production capacities remain
available on unchanged terms. This will also allow the company to now draw
benefits in the classic health products area. In view of these
circumstances, and in the expectation of the further growing importance of
the VitaDock series, which should be particularly evident in the
fourth-quarter business trend, the Management Board is assuming that it
will achieve a further earnings improvement in 2012, and a return to
operating profitability.
Forthcoming dates
07/-09/05/2012 Entry and GeneralStandard Conference, Frankfurt am Main
19/05/2012 Publication of Group 2012 interim report within first half of
2012
26/06/2012 Ordinary Annual General Meeting, Düsseldorf
31/08/2012 Publication of H1 2012 financial report
31/08/-05/09/2012 IFA international consumer electronics and home
appliances trade fair 2012, Berlin
14/-17/11/2012 Medica trade fair, Düsseldorf
19/11/2012 Publication of Group 2012 interim report within second half of
2012
MEDISANA AG
Jagenbergstrasse 19, 41468 Neuss
Tel.: +49 (0) 2131 / 36 68 0
Fax: +49 (0) 2131 / 36 68 50 95
info(at)medisana.de
www.medisana.de
End of Corporate News
---------------------------------------------------------------------
02.05.2012 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Medisana AG
Jagenbergstr. 19
41468 Neuss
Germany
Phone: +49 (0)2131-3668 5410
Fax: +49 (0)2131- 3668 5095
E-mail: info(at)medisana.de
Internet: www.medisana.de
ISIN: DE0005492540
WKN: 549254
Listed: Regulierter Markt in Frankfurt (General Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
167795 02.05.2012
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Woulfe Mining Strategic Partner IMC, Signed MOU With Korean Government on Development of Sangdong Mine
Datum: 02.05.2012 - 12:24 Uhr
Sprache: Deutsch
News-ID 1109841
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 69 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Medisana AG: Significant earnings improvement, Mobile health encounters enormous interest
"
steht unter der journalistisch-redaktionellen Verantwortung von
Medisana AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
